Personal information

Keywords

Oncology, Oncotherapy, Tumor immunology, Complementary and alternative medicine

Countries

China

Activities

Collapse all

Employment (1)

TMR Publishing Group: Auckland, Auckland, NZ

2021-07-19 to present (Editorial Department)
Employment
Source: Self-asserted source
Jinfeng Liu

Education and qualifications (2)

Tianjin Medical University: Tianjin, He-Ping District, CN

2018-08-21 to 2021-07-05 (Graduate School)
Qualification
Source: Self-asserted source
Jinfeng Liu

Qinghai University: Xining, Qinghai Province, CN

2012-09-10 to 2017-06-05 (Department of Clinical Medicine, School of Medicine)
Qualification
Source: Self-asserted source
Jinfeng Liu

Professional activities (1)

China Anti-Cancer Association: Tianjin, CN

2018-10-05 to present (Tianjin Medical University Cancer Institute and Hospital)
Service
Source: Self-asserted source
Jinfeng Liu

Funding (2)

Study on The Mechanism of Huoxue Huayu Method Against Breast Cancer Metastasis Based on The Interference of MDSCs With The Formation of The Microenvironment Before Metastasis

2020-01 to 2022-12 | Grant
National Natural Science Foundation of China (Tianjin, Nan-Kai District, CN)
Part of GRANT_NUMBER:

81903934
Source: Self-asserted source
Jinfeng Liu

Research on Anti-tumor Biomechanical Mechanism of Ruanjian Sanjie Traditional Chinese Medicine

2015-01 to 2018-12 | Grant
National Natural Science Foundation of China (Tianjin, He-Ping District, CN)
Part of GRANT_NUMBER:

81473441
Source: Self-asserted source
Jinfeng Liu

Works (4)

Epigenetically regulated gene expression profiles reveal four molecular subtypes with prognostic and therapeutic implications in colorectal cancer.

Briefings in bioinformatics
2021-07-01 | Journal article
Funded by DOI: 10.1093/bib/bbaa309
Part of PMID: 33300554
Source: Self-asserted source
Jinfeng Liu

Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients.

Journal of cancer research and clinical oncology
2021-04-02 | Journal article
Funded by DOI: 10.1007/s00432-020-03488-0
PMID: 33797608
Source: Self-asserted source
Jinfeng Liu

Network Pharmacology-Based and Clinically Relevant Prediction of the Potential Targets of Chinese Herbs in Ovarian Cancer Patients.

BioMed research international
2020-10-08 | Journal article
Funded by DOI: 10.1155/2020/8965459
PMID: 33150184
PMC: PMC7603558
Source: Self-asserted source
Jinfeng Liu

A novel CpG-methylation-based nomogram predicts survival in colorectal cancer.

Epigenetics
2020-05-12 | Journal article
Funded by DOI: 10.1080/15592294.2020.1762368
PMID: 32396412
Part of PMC: PMC7595584
Source: Self-asserted source
Jinfeng Liu
How many people are using ORCID?